Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.

Regenersis plc (RGS)     

dreamcatcher - 26 Sep 2012 20:57




We help our clients and their customers successfully deploy,
protect, maintain, retire and re-use technology.


The world is witnessing explosive growth in the number of connected devices, and in the power and complexity of mobile computing platforms. This is resulting in an increasing need for sophisticated technology- and user support. Regenersis addresses those needs with a growing portfolio of software-rich services building on a strong heritage of repair operations, customer service and data erasure management.

By combining our capabilities in innovative ways, tailored to individual client requirements, we deliver unique service propositions that reinforce trust in our client’s brands and create value for our business partners and shareholders.


Technology Life Cycle Services

Our international network of repair centres provides product repair, refurbishment, parts management and logistics services for mobile, IT, home entertainment and B2B infrastructure product vendors; and their sales channels, insurers, and end users. Our technically-advanced repair capabilities enjoy a solid reputation with our TMT sector clients, combining service excellence with continuous gains in cost efficiency.

Our industry-leading fault diagnostics and issue resolution technologies include the In-Field Tester for set top boxes, and our SmartChk applications suite for smartphones. These advanced diagnostic platforms improve consumer satisfaction with their devices and materially reduce the incidence and cost of product returns for our clients.

In partnership with leading insurers, our Digital Care operations deliver innovative product insurance and extended warranty programmes for our clients, protecting customers’ investments in mobile technology products.

Our Recommerce division helps manufacturers and retailers to launch products and attract new customers through upgrade and buy-back programmes.

Blancco is the global leader in data erasure management (DEM). Blancco software provides comprehensive data erasure for every type of electronic and magnetic storage media, ranging from portable flash drives and mobile phone memory to solid state drives, networked storage, virtual drives and cloud storage. Blancco DEM is a vital part of any organisation’s security infrastructure, underpinning robust data retention policies and ensuring compliance with international data protection regulations.

Regenersis around the world

Our clients increasingly seek partners who can deliver cost-effective and innovative technology life cycle services on a global basis. Since 2011, Regenersis has expanded its geographical footprint from five countries to 16. With the acquisition of Blancco in April 2014, this increased to 22 countries.



http://www.regenersis.com/about-us



Chart.aspx?Provider=EODIntra&Code=RGS&SiChart.aspx?Provider=EODIntra&Code=RGS&Si




Final Results

http://www.moneyam.com/action/news/showArticle?id=4451090

Financial Highlights

·
Group revenue increased by 13% to £139.9 million (2011: £123.8 million)

·
Headline operating profit(*) increased by 24% to £7.8 million (2011: £6.3 million)

·
Operating cash flow improved to £4.9 million (2011: £2.4 million).

·
Further Improvement in headline operating margin to 5.5% (2011: 5.1%)

·
Net debt reduced to £2.9 million (2011: £3.8 million)

·
Banking facility extended from £15 million to £23.25 million for the period to October 2015, to support further organic investment and incremental M&A activity

·
First dividend payment since 2007 - recommended final dividend of 1.1 pence per ordinary share

dreamcatcher - 26 Sep 2013 17:00 - 83 of 183

I thought so. :-))

goldfinger - 27 Sep 2013 08:24 - 84 of 183

DC just filter him. hes a waste of space.

dreamcatcher - 27 Sep 2013 15:21 - 85 of 183

IC today - Regenersis charging ahead.

Chief executive Matthew Peacock is confident the group can achieve double-digit revenue and earnings growth for the next three years.


Regenersis is becoming the dominant player in the market and also boasts a strong balance sheet. They still trade on 14 times forecast earnings. That looks too modest given the potential for further growth and market share wins.

dreamcatcher - 03 Oct 2013 17:21 - 86 of 183

A buy in this weeks Shares - Directors buying sends vote of confidence. Stock broker Panmure Gordon increased its price target from 240p to 302p on the back of the results.

goldfinger - 11 Oct 2013 09:33 - 87 of 183

Just bought these back and may be taking a big gamble with the ongoing US problem. My first purchase in about 2weeks.

regen%201.JPG

dreamcatcher - 11 Oct 2013 15:49 - 88 of 183

Any decent company seems to be holding up well in these uncertain market times.

dreamcatcher - 15 Oct 2013 18:43 - 89 of 183

Sp climbing hard since 1 sept.

goldfinger - 15 Oct 2013 18:46 - 90 of 183

Going well, itl do me.

dreamcatcher - 16 Oct 2013 21:06 - 91 of 183

I see the Naked trader has a target price of 280p

dreamcatcher - 17 Oct 2013 18:04 - 92 of 183

Four pages in this weeks Shares covering 4 directors buys and RGS being one of them. It focuses on Joc Dhody the chief financial officer. His most successful past trade was 155,987 shares purchased in Sept 12 to then go on to gain 112%. His most recent buy was 24 Sept 13 - 39,000 shares at 255p . A good signal being sent to the market. Panmure Gordon states it is the 'go to' solutions house for the industry. Cenkos says the shares could be re-valued towards 400p.

goldfinger - 17 Oct 2013 18:11 - 93 of 183

Yep back to form today.

dreamcatcher - 23 Oct 2013 17:29 - 94 of 183

Regenersis PLC (RGS:LSE) set a new 52-week high during Tuesday's trading session when it reached 284.00. Over this period, the share price is up 114.94%.

dreamcatcher - 01 Nov 2013 16:04 - 95 of 183


Director/PDMR Shareholding

RNS


RNS Number : 9706R

Regenersis PLC

01 November 2013






REGENERSIS PLC



(the "Company")



Director shareholding



Regenersis plc, a strategic outsourcing partner to many of the world's leading consumer technology companies has received notification that Hanover Investors Management (Cayman) Ltd has on 31 October 2013 acquired 40,000 ordinary shares in the Company at a price of 256p per share.



Following this acquisition, Hanover Investors and its connected parties are interested in 10,826,637 shares (representing 21.8% of the issued share capital). Matthew Peacock and Tom Russell, both executive directors of the Company, have an indirect beneficial interest in the shares held by Hanover Investors through their association with Hanover Investors.

dreamcatcher - 04 Nov 2013 16:57 - 96 of 183

Bodes well -
Director Deals - Regenersis PLC (RGS)

BFN

Rob Woodward, Non Executive Director, bought 4,459 shares in the company on the 4th November 2013 at a price of 269.52p. The Director now holds 4,459 shares.

Story provided by StockMarketWire.com
Director deals data provided by www.directorsholdings.com

dreamcatcher - 14 Nov 2013 15:45 - 97 of 183

Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 290.70. Over this period, the share price is up 99.79%.

dreamcatcher - 15 Nov 2013 15:18 - 98 of 183

up another 7%

dreamcatcher - 15 Nov 2013 17:19 - 99 of 183

IC today - Regenersis rings the right tune.

Judging by the actions of the company's board members . the shares could still have some way to go. Chairman Matthew Peacock and director Tom Russell recently purchased 40,000 shares at 256p each, totalling £102,400. Independentb non executive director Rob Woodward snapped up 4,459 at 269p on 4 Nov, which followed finance director Jog Dhody's purchase of 39,000 shares on 24 Sept at 255p.
After a significant re-rating , the shares are trading on 15 times forward earnings, but given the potential for double digit EPS growth over the next two years and the fact that the company's directors are piling into the shares, we would suggest to run profits.

dreamcatcher - 15 Nov 2013 17:23 - 100 of 183

Closed up 9.11%

Chart.aspx?Provider=EODIntra&Code=RGS&Si

dreamcatcher - 27 Nov 2013 20:40 - 101 of 183

Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 327.00. Over this period, the share price is up 137.73%.

As of Nov 23, 2013, the consensus forecast amongst 3 polled investment analysts covering Regenersis PLC advises investors to purchase equity in the company

dreamcatcher - 28 Nov 2013 15:17 - 102 of 183

Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 345.00. Over this period, the share price is up 152.75%.
Register now or login to post to this thread.